Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RECQL | P46063 | 1/20 | 0.54 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.36 |
| ▸ | LMNA | P02545 | 2/20 | 0.36 |
| ▸ | MAPT | P10636 | 1/20 | 0.36 |
| ▸ | RAB9A | P51151 | 2/20 | 0.35 |
| ▸ | GLA | P06280 | 1/20 | 0.35 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.34 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.32 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | NPC1 | O15118 | 1/20 | 0.32 |
| ▸ | ATM | Q13315 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Acetone SCHEMBL4249268 | 0.73 | CA12 (0.36) | RECQLCYP2C19ALDH1A1LMNAMAPT | |
| Acetone SCHEMBL15539197 | 0.73 | NNMT (0.33) | RECQLCYP2C19RAB9AGLAKMT2A | |
| Acetone SCHEMBL20164099 | 0.72 | CA12 (0.35) | RECQLCYP2C19ALDH1A1LMNAMAPT | |
| SCHEMBL5667071 | 0.68 | CA12 (0.38) | RECQLCYP2C19ALDH1A1MAPTRAB9A | |
| SCHEMBL15634880 | 0.68 | NNMT (0.33) | RECQLCYP2C19RAB9A | |
| SCHEMBL11226245 | 0.67 | KDM4E (0.51) | ALDH1A1LMNAMAPTRAB9AL3MBTL1 | |
| Hydrochloric Acid SCHEMBL7268096 | 0.67 | CA12 (0.37) | CYP2C19ALDH1A1MAPTRAB9AL3MBTL1 | |
| SCHEMBL24610121 | 0.65 | KDM4E (0.44) | ALDH1A1LMNARAB9ARXFP1KDM4E | |
| Acetone SCHEMBL2190153 | 0.64 | KDM4E (0.35) | RECQLALDH1A1RAB9AKDM4EKMT2A | |
| SCHEMBL28270307 | 0.64 | MAPT (0.60) | CYP2C19ALDH1A1LMNAMAPTL3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7265213-B2 | Methodology of conjugating chelators to biomolecules | KPL, INC. (US) | 2007-09-04 | — | — | US | disclosed |
| US-20070026535-A1 | Novel methodology of conjugating chelators to biomolecules | KPL, INC. (US) | 2007-02-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070026535-A1 | Novel methodology of conjugating chelators to biomolecules | SLC40A1, SLC30A6, CACYBP | RECQL 2574/4885CYP2C19 4531/4885ALDH1A1 3698/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.